Top Stories

Study Reveals Link Between Insomnia, Genetics And Heart Disease

Study Reveals Link Between Insomnia, Genetics And Heart Disease
Written by Vincent Wilmot

As per the new study, researchers have found many gene regions linked to insomnia, also connecting between insomnia and several heart diseases. Researchers from America and Britain have stated that more than 450,000 people from the United Kingdom are reported for frequent sleeplessness, also identifying 57 gene regions related to insomnia. Risk factors such as consumption of caffeine, depression, stress or lifestyle were known as independent links causing insomnia.  The current study of researchers confirmed the role of genetics in the symptoms related to insomnia and provides expansion to the previously found 4 genetic regions that triggered insomnia.

All of these detected regions can help people understand why they get insomnia, what all is affected and help them targeting effective therapy or remedies towards it. Researchers have also found evidence which indicates that insomnia symptoms increase the risk of coronary artery problems. They were also believed to be associated with depression causing a lower sensation of well-being.

Insomnia has a vital role in impacting a vast population worldwide. It has been know from years that there’s some relation between insomnia and chronic disease. Now, the recent study shows that insomnia can be the reason leading to heart problems and depression. All of the found regions are therapeutic targets, and 16 of these have drug targets as per the report. The casual relationship recommends probable use of insomnia therapeutics as treatments which are possible to cure chronic diseases and depression.

Insomnia affects about 10 to 20 % population worldwide, and facts have proven that inheritance relates to one-third of the risk of insomnia. As per previous research, insomnia is known to increase the risk of anxiety, dominant depression syndrome, heart diseases, and alcoholism but less was known about the mechanisms involved in these risks.

This recent results of the study will enhance possibilities for all future treatment and medication for insomnia.

About the author

Vincent Wilmot

Vincent Wilmot has been working with us for 2 years and with his hard work and efforts has earned the position of Senior Content Writer in a short span. He handles the content and news reporting of Business world; right from the latest trends, to mergers & acquisitions, to news and much more. In spare time, Vincent likes to go play with the share market numbers along with enjoying trekking and hiking with his friends.

Leave a Comment